75 Researchers Confirmed to Present at Extracellular Biomarkers Summit, March 2015 in Boston Area

NEEDHAM, Mass. - Oct. 22, 2014 - PRLog -- Cambridge Healthtech Institute is pleased to announce the final agenda for the newest addition to its biomarker and diagnostic portfolio, Extracellular Biomarkers Summit. Taking place March 16-18, 2015 in Cambridge, MA, the event merges the well-established microRNA as Biomarkers and Diagnostics Conference with similar areas of current research in the field. Coverage will include the role of circulating microRNA, exosomes and microvesicles, long non-coding RNA and extracellular RNA in cancer and other diseases, as well as their potential to serve as biomarkers in drug and diagnostic development.

Presentations and discussions will also focus on the isolation and characterization of exosomes and exRNA, including expression profiling and sequencing of exRNA; understanding the role of miRNA, lncRNA, and exosomes in disease mechanism, tumor metastasis, and intracellular communication; their potential as biomarkers in drug development, drug toxicity assessment, and patient stratification; and finally, their role as circulating biomarkers for disease diagnosis and prognosis.

Leading the program is a speaking faculty of 75 pharma, biotech and academic researchers including: The Ohio State University’s Genetics Institute Director, Carlo Croce; Isis Pharmaceuticals’ Vice President, Susan Freier; Baylor Research Institute’s Director of Cancer Prevention Ajay Goel; MD Anderson Cancer Center’s Chair of Cancer Biology, Raghu Kalluri; Merck’s Clinical Development Laboratory Director, Omar Laterza; and Novartis’ RNA Biology Senior Investigator, Nicole Meisner-Kober.

Full program details can be found at http://www.extracellularbiomarkers.com. Early registration rates apply and are available until December 12, 2014.

About Cambridge Healthtech Institute

Cambridge Healthtech Institute (CHI) (http://www.chicorporate.com), founded in 1992, is the industry leader in providing superior-quality scientific information to eminent researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett Educational Services, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, Cambridge Healthtech Media Group, and the Knowledge Foundation.